TissGeneSummary for SLC35G6 |
Gene summary |
Basic gene information | Gene symbol | SLC35G6 |
Gene name | solute carrier family 35, member G6 | |
Synonyms | AMAC1L3|TMEM21B | |
Cytomap | UCSC genome browser: 17p13.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001102614.1, | |
Description | acyl-malonyl condensing enzyme 1-like 3acyl-malonyl-condensing enzyme 1-like protein 3protein AMAC1L3solute carrier family 35 member G6transmembrane protein 21B | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_SLC35G6 | |
BioGPS: 643664 | ||
Pathway | NCI Pathway Interaction Database: SLC35G6 | |
KEGG: SLC35G6 | ||
REACTOME: SLC35G6 | ||
Pathway Commons: SLC35G6 | ||
Context | iHOP: SLC35G6 | |
ligand binding site mutation search in PubMed: SLC35G6 | ||
UCL Cancer Institute: SLC35G6 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of SLC35G6 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for SLC35G6 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for SLC35G6 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for SLC35G6 |
TissGeneSNV for SLC35G6 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E333K | PAAD | 7 |
p.E333A | PCPG | 4 |
p.A127T | ESCA | 2 |
p.E333K | DLBC | 1 |
p.G96E | BLCA | 1 |
p.Y299N | HNSC | 1 |
p.A263T | COAD | 1 |
p.G237A | KIRP | 1 |
p.G312W | COAD | 1 |
p.E333A | DLBC | 1 |
p.R90C | COAD | 1 |
p.A263D | KIRC | 1 |
p.W27R | LIHC | 1 |
p.V144I | UCEC | 1 |
p.G334E | SKCM | 1 |
p.R26H | LUSC | 1 |
p.S58F | ACC | 1 |
p.G153V | KIRC | 1 |
p.R76* | UCEC | 1 |
p.V54M | KIRP | 1 |
p.S13A | LIHC | 1 |
p.A273P | TGCT | 1 |
p.G237S | SKCM | 1 |
p.G237D | UCEC | 1 |
p.V290A | LUSC | 1 |
p.S120G | DLBC | 1 |
p.S13Y | UCEC | 1 |
p.P98S | SKCM | 1 |
p.G206E | LGG | 1 |
p.L81I | STAD | 1 |
p.E333A | UVM | 1 |
p.P22S | SKCM | 1 |
Top |
TissGeneCNV for SLC35G6 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for SLC35G6 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | PRAD | TCGA-KC-A7FD-01A | MRPL39-SLC35G6 | In-Frame | chr21:26972110 | chr17:7385306 |
TCGAfusionPortal | PRADA | BRCA | TCGA-A2-A1G1-01A | SLC35G6-ALOX12 | In-frame | Chr17:7388176 | Chr17:6903655 |
TCGAfusionPortal | PRADA | BRCA | TCGA-A8-A07O-01A | SLC35G6-SLC16A13 | In-frame | Chr17:7399392 | Chr17:6941471 |
TCGAfusionPortal | PRADA | LAML | TCGA-AB-2938-03A | SLC35G6-FBN3 | Out-of-frame | Chr17:7388176 | Chr19:8156474 |
TCGAfusionPortal | PRADA | PRAD | TCGA-KC-A7FD-01A | MRPL39-SLC35G6 | In-frame | Chr21:26972111 | Chr17:7385307 |
Top |
TissGeneNet for SLC35G6 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for SLC35G6 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for SLC35G6 |
TissGeneDrug for SLC35G6 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for SLC35G6 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0006142 | Malignant neoplasm of breast | 1 | GAD |